Clinical Trials Browser

Recruiting × Urinary Bladder Neoplasms × sacituzumab govitecan × Clear all

NCT04724018 2025-11-04

Sacituzumab Govitecan Plus EV in Metastatic UC

Phase 1/2 Recruiting

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell